Evidence map›Paper›PMID 21747924›Full record

ArticlePloS one2011

Memory B cells and CD8⁺ lymphocytes do not control seasonal influenza A virus replication after homologous re-challenge of rhesus macaques.

Timothy D Carroll, Shannon R Matzinger, Linda Fritts, Michael B McChesney, Christopher J Miller

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.4field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Influenza A Reinfection in Sequential Human Challenge: Implications for Protective Immunity and "Universal" Vaccine Development.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2020
    Article
  3. Review
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Timothy D CarrollCenter for Comparative Medicine, University of California Davis, Davis, California, United States of America.
Shannon R Matzinger
Linda Fritts
Michael B McChesney
Christopher J Miller
University of California, Davis · US

Funding

ZONA PELLUCIDA PEPTIDES AS IMMUNOCONTRACEPTIVE ANTIGENSP51RR000169 · NCRR · UNIVERSITY OF CALIFORNIA DAVIS · PI HYDE, DALLAS MELVIN · 1985 to 2011
$126.2M
Pulmonary innate immune activation for bioterror defenseU01AI057264 · NIAID · COLEY PHARMACEUTICAL GROUP, INC. · PI KRIEG, ARTHUR M. · 2003 to 2005
$6.3M
NCRR NIH HHS P51 RR000169NCRR NIH HHS P51RR00169NIAID NIH HHS U01 AI057264NIAID NIH HHS U01AI5726NIAID NIH HHS U01AI57624
6 · The paper itself

Abstract

This study sought to define the role of memory lymphocytes in the protection from homologous influenza A virus re-challenge in rhesus macaques. Depleting monoclonal antibodies (mAb) were administered to the animals prior to their second experimental inoculation with a human seasonal influenza A virus strain. Treatment with either anti-CD8α or anti-CD20 mAbs prior to re-challenge had minimal effect on influenza A virus replication. Thus, in non-human primates with pre-existing anti-influenza A antibodies, memory B cells and CD8α⁺ T cells do not contribute to the control of virus replication after re-challenge with a homologous strain of influenza A virus.

Indexed as

SeasonsAnimalsAntibodies, MonoclonalAntigens, CD20B-Lymphocyte SubsetsCD8 AntigensCD8-Positive T-LymphocytesHumansImmunity, InnateImmunizationInfluenza A Virus, H1N1 SubtypeKiller Cells, NaturalMacaca mulattaSpecies SpecificityVirus ReplicationAntibodies, MonoclonalAntigens, CD20CD8alpha antigenCD8 Antigens

Identifiers

PMID21747924
PMCPMC3126839
OpenAlexW2067550184

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.